share_log

Ping An Healthcare and Technology Company Limited (HKG:1833) Is Expected To Breakeven In The Near Future

Ping An Healthcare and Technology Company Limited (HKG:1833) Is Expected To Breakeven In The Near Future

平安醫療科技股份有限公司(HKG: 1833)預計將在不久的將來實現盈虧平衡
Simply Wall St ·  05/20 23:59

Ping An Healthcare and Technology Company Limited (HKG:1833) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in China. The HK$14b market-cap company announced a latest loss of CN¥323m on 31 December 2023 for its most recent financial year result. Many investors are wondering about the rate at which Ping An Healthcare and Technology will turn a profit, with the big question being "when will the company breakeven?" In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

平安醫療科技股份有限公司(HKG: 1833)的業務可能即將取得重大成就,因此我們想對該公司有所了解。平安醫療科技有限公司及其子公司在中國運營在線醫療服務平台。這家市值140億港元的公司於2023年12月31日宣佈其最新財年業績虧損3.23億元人民幣。許多投資者想知道平安醫療科技的盈利速度,最大的問題是 “公司何時會實現盈虧平衡?”在本文中,我們將介紹對公司增長的預期以及分析師預計何時實現盈利。

Consensus from 14 of the Hong Kong Consumer Retailing analysts is that Ping An Healthcare and Technology is on the verge of breakeven. They anticipate the company to incur a final loss in 2025, before generating positive profits of CN¥93m in 2026. So, the company is predicted to breakeven approximately 2 years from today. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 42%, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

14位香港消費零售分析師一致認爲,平安醫療科技正處於盈虧平衡的邊緣。他們預計該公司將在2025年蒙受最終虧損,然後在2026年產生9300萬元人民幣的正利潤。因此,預計該公司將在大約兩年後實現盈虧平衡。爲了在這一天實現盈虧平衡,公司必須同比增長多少?使用最適合的線,我們計算出平均年增長率爲42%,這相當樂觀!如果事實證明這個利率過於激進,該公司的盈利時間可能比分析師預測的要晚得多。

earnings-per-share-growth
SEHK:1833 Earnings Per Share Growth May 21st 2024
SEHK: 1833 每股收益增長 2024 年 5 月 21 日

We're not going to go through company-specific developments for Ping An Healthcare and Technology given that this is a high-level summary, but, keep in mind that by and large a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

鑑於這是一份高層次的總結,我們不會詳細介紹平安醫療與科技公司的具體發展情況,但是,請記住,總的來說,對於目前處於投資期的公司來說,高預測增長率並不少見。

Before we wrap up, there's one aspect worth mentioning. The company has managed its capital prudently, with debt making up 0.08% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

在我們總結之前,有一個方面值得一提。該公司謹慎地管理其資本,債務佔股權的0.08%。這意味着其運營資金主要來自股權資本,其低債務債務降低了投資這家虧損公司的風險。

Next Steps:

後續步驟:

There are key fundamentals of Ping An Healthcare and Technology which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Ping An Healthcare and Technology, take a look at Ping An Healthcare and Technology's company page on Simply Wall St. We've also put together a list of pertinent factors you should further examine:

本文未涵蓋平安醫療與科技的關鍵基礎知識,但我們必須再次強調,這只是一個基本的概述。要更全面地了解平安醫療與科技,請查看平安醫療科技在Simply Wall St上的公司頁面。我們還整理了一份你應該進一步研究的相關因素清單:

  1. Valuation: What is Ping An Healthcare and Technology worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Ping An Healthcare and Technology is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Ping An Healthcare and Technology's board and the CEO's background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
  1. 估值:平安醫療與科技今天的價值是多少?價格中是否已經考慮了未來的增長潛力?我們免費研究報告中的內在價值信息圖有助於可視化平安醫療科技目前是否被市場錯誤定價。
  2. 管理團隊:由經驗豐富的管理團隊掌舵增強了我們對業務的信心——看看誰是平安醫療科技董事會成員以及首席執行官的背景。
  3. 其他表現優異的股票:還有其他股票可以提供更好的前景並有良好的往績記錄嗎?在這裏瀏覽我們免費列出的這些優質股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論